In this report, we explore the oncology market landscape in China and market access initiatives of companies offering cancer treatments, to help pharmaceutical companies to understand how to better facilitate early and expanded access to this market. The report looks at:

  • The impact of recent medical reforms on market access
  • How are market access challenges complicating patient pathways to cancer care
  • Availability: How are companies overcoming the early market access challenges faced in China
  • Pricing: How are patients, the government, payers, providers and market distributors interacting with prevailing cancer drug prices
  • Reimbursement: The outlook for negotiation

Download report